Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
84.22
+1.01 (1.21%)
At close: Jul 27, 2026, 4:00 PM EDT
84.31
+0.09 (0.11%)
After-hours: Jul 27, 2026, 7:45 PM EDT

Medtronic Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
36,36433,53732,36431,22731,686
Revenue Growth
8.43%3.62%3.64%-1.45%5.21%
Cost of Revenue
12,72111,63211,21610,71910,145
Gross Profit
23,64321,90521,14820,50821,541
Selling, General & Admin
11,78410,84910,73610,41510,292
Depreciation & Amortization Expenses
1,7721,8071,6931,6981,733
Research & Development
2,8732,7322,7352,6962,746
Other Operating Expenses
7485618392141,017
Total Operating Expenses
17,17715,94916,00315,02315,788
Operating Income
6,4675,9555,1445,4855,752
Interest Expense
-715-729-719-636-553
Other Non-Operating Income (Expense)
384402412515318
Total Non-Operating Income (Expense)
-331-327-307-121-235
Pretax Income
6,1365,6284,8375,3645,517
Provision for Income Taxes
1,2999361,1331,580456
Net Income
4,8374,6913,7053,7845,062
Minority Interest in Earnings
3729282622
Net Income to Common
4,8014,6623,6763,7585,039
Net Income Growth
2.98%26.82%-2.18%-25.42%39.74%
Shares Outstanding (Basic)
1,2821,2861,3281,3301,342
Shares Outstanding (Diluted)
1,2881,2901,3301,3331,351
Shares Change
-0.14%-3.03%-0.19%-1.38%-0.19%
EPS (Basic)
3.753.632.772.833.75
EPS (Diluted)
3.733.612.762.823.73
EPS Growth
3.32%30.80%-2.13%-24.40%40.23%

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Free Cash Flow
5,4265,1855,2004,5805,978
Free Cash Flow Growth
4.65%-0.29%13.54%-23.39%22.38%
Free Cash Flow Per Share
4.214.023.913.444.42
Dividends Per Share
2.8402.8002.7602.7202.520
Dividend Growth
1.43%1.45%1.47%7.94%8.62%
Gross Margin
65.02%65.32%65.34%65.67%67.98%
Operating Margin
17.78%17.76%15.89%17.56%18.15%
Profit Margin
13.30%13.99%11.45%12.12%15.98%
FCF Margin
14.92%15.46%16.07%14.67%18.87%
EBITDA
9,4258,8167,7918,1828,459
EBITDA Margin
25.92%26.29%24.07%26.20%26.70%
EBIT
6,4675,9555,1445,4855,752
EBIT Margin
17.78%17.76%15.89%17.56%18.15%
Effective Tax Rate
21.17%16.63%23.42%29.46%8.27%
SEC Filings: 10-K · 10-Q